HOME >> MEDICINE >> NEWS
Potential cure for lymphoma in HIV patients

(WASHINGTON, January 7, 2005) Stem cell transplants have become the standard of care for Patients with relapsed lymphoma, but not for Patients who suffer from both this disease and HIV. A new study showing that this treatment is a viable option for select Patients with HIV-associated lymphoma will be published in the January 15, 2005, issue of Blood, the official journal of the American Society of Hematology.

Because of the immunodeficiency associated with HIV, HIV-positive Patients are more likely to develop lymphoma than HIV-negative individuals, and the treatment for their cancer is far less likely to be successful.

Sonali Smith, M.D., Assistant Professor of Medicine at the University of Chicago notes, "The treatment of malignant lymphomas in HIV-infected individuals remains challenging, due to both the high incidence of refractory disease and the high risk of treatment-related complications. The ability of high dose chemotherapy as demonstrated in this pilot study to effectively treat even refractory disease is highly encouraging and certainly warrants further study."

Researchers from the City of Hope Cancer Center studied 20 Patients (aged 11 to 68) who had HIV and lymphoma, either Hodgkin's or non-Hodgkin's. The selected Patients had undergone previous standard-dose frontline chemotherapy for their lymphoma, but the majority either failed to achieve a complete remission or had relapsed after an initial remission. The median length of study follow-up was approximately two and a half years, with a range of about six months to six years.

All study Patients were to undergo autologous stem cell rescue. In an autologous transplant, stem cells are removed from the patient and frozen for later use. The patient receives high-dose chemotherapy to kill any lymphoma in the body, and the autologous stem cells are then infused back into the patient to repopulate the bone marrow wiped out by the chemotherapy.

Before the trans
'"/>

Contact: Laura Stark
lstark@hematology.org
American Society of Hematology
7-Jan-2005


Page: 1 2 3

Related medicine news :

1. Potential treatment for Fragile X Syndrome demonstrated in fruit fly model
2. Potential drug target for treating cocaine abuse found
3. Potentially fatal toxicities occur with off-label use of cancer drugs
4. Potentially blinding eye disease more prevalent than previously thought
5. Potential genetic links discovered between metabolic syndrome, diabetes and cardiovascular disease
6. Potential low-cost options for monitoring HIV-1-infected children in less-developed countries
7. Immunexs TRAIL Molecule Shows Potential As Anti-Tumor Agent
8. Study Shows Potential For Quelling AIDS Nerve Pain
9. Polish Dumpling-Like Particle Has Potential In Drug Delivery
10. Increased Public Access To Defibrillation Could Prove Potentially Cost-Effective And Life-Saving
11. Anti-Clotting Drug May Cause Potentially Fatal Platelet Disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... SPRINGS, Miss. (PRWEB) , ... August 31, 2020 ... ... Plus (GCPP) recently donated 1,400 N95 face masks to medical first responders across ... has continued to make donations of personal protective equipment (PPE) medical centers ...
(Date:8/31/2020)... ... August 31, 2020 , ... Genesis Chiropractic Software ... today the launch of its integrated, HIPAA compliant, telehealth solution, available to US-based ... in under 90 seconds. , According to the U.S. Department of Health ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... support services to dental groups in the United States, today announced the grand ... of Beaumont, CA. , Patients will enjoy convenient hours, a comfortable office, ...
(Date:8/31/2020)... ... ... “PTS” with Mediation & Hypnosis , At this very turbulent time in the world, ... immense stress, and right now are needing serious relief from a constant state of endless ... experiencing a great degree of emotional discomfort, be it fear or worrying about their income ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang has over ... autism and other developmental disabilities, as well as supporting staff in caring for ... autism, school consultation, and staff development. She joined the company in 2015 as ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... Colo. (PRWEB) , ... September 03, 2020 , ... ... Colorado at Boulder’s Vance Lab ( https://www.colorado.edu/lab/vance/masks ), an aerosol and engineering lab, ... can provide better protection against the COVID-19 virus than many other masks. Q&J ...
(Date:9/2/2020)... ... September 02, 2020 , ... Rigaku Analytical Devices ... discussion among industry professionals about successes and challenges of making changes to their ... Review and will take place on October 15, 2020 at 10:00am PDT ...
(Date:9/1/2020)... ... September 01, 2020 , ... Agilent, a global ... Agilent Science and Technology Virtual Symposium 2020 (ASTVS 2020) on September 10-11, ... suite of Live webinars and Networking sessions, with a vast array of on-demand ...
Breaking Medicine Technology:
Cached News: